GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Protia Inc (XKRX:303360) » Definitions » EV-to-EBIT

Protia (XKRX:303360) EV-to-EBIT : 12.35 (As of Apr. 29, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Protia EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Protia's Enterprise Value is ₩28,938 Mil. Protia's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was ₩2,343 Mil. Therefore, Protia's EV-to-EBIT for today is 12.35.

The historical rank and industry rank for Protia's EV-to-EBIT or its related term are showing as below:

XKRX:303360' s EV-to-EBIT Range Over the Past 10 Years
Min: 9.17   Med: 35.27   Max: 288
Current: 12.34

During the past 7 years, the highest EV-to-EBIT of Protia was 288.00. The lowest was 9.17. And the median was 35.27.

XKRX:303360's EV-to-EBIT is ranked better than
71.56% of 109 companies
in the Medical Diagnostics & Research industry
Industry Median: 20.05 vs XKRX:303360: 12.34

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Protia's Enterprise Value for the quarter that ended in Dec. 2024 was ₩22,048 Mil. Protia's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was ₩2,343 Mil. Protia's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 10.63%.


Protia EV-to-EBIT Historical Data

The historical data trend for Protia's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protia EV-to-EBIT Chart

Protia Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
Get a 7-Day Free Trial -22.26 -78.89 54.99 58.23 9.41

Protia Quarterly Data
Dec18 Dec19 Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.23 33.44 20.88 17.73 9.41

Competitive Comparison of Protia's EV-to-EBIT

For the Diagnostics & Research subindustry, Protia's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Protia's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Protia's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Protia's EV-to-EBIT falls into.


;
;

Protia EV-to-EBIT Calculation

Protia's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=28938.275/2343.347
=12.35

Protia's current Enterprise Value is ₩28,938 Mil.
Protia's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩2,343 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Protia  (XKRX:303360) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Protia's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 ) =EBIT / Enterprise Value (Q: Dec. 2024 )
=2343.347/22048.376
=10.63 %

Protia's Enterprise Value for the quarter that ended in Dec. 2024 was ₩22,048 Mil.
Protia's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩2,343 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Protia EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Protia's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Protia Business Description

Traded in Other Exchanges
N/A
Address
Room 702, Building A, 401 Yangcheon-ro, Gangseo-gu, Seoul, KOR, 07528
Protia Inc is a South Korean company engaged in research and development, manufacturing and sales of in vitro diagnostic medical devices and diagnostic reagents. Their main product is allergy diagnostic products for humans and animals,' as well as various immunochemical in vitro diagnostic products.

Protia Headlines

No Headlines